Stock Market News
Bristol Myers discloses $39 million in Russia exit costs
2022.07.27 20:42
Test tubes are seen in front of a displayed Bristol Myers Squibb logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic/Illustration
(Reuters) – Bristol Myers (NYSE:BMY) Squibb Co said on Wednesday it had transferred its commercial operations in Russia to a third-party distributor and incurred $39 million in related costs.
The drugmaker said in a filing that its remaining assets in the country were not material. (https://